Skip to main content

Table 1 The ITT populations with and without prior cannabis use in each of the studies

From: Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach

 

Sativex® (n = 356)

Placebo (n = 296)

Total (n = 652)

 

PC

No PC

PC

No PC

PC

No PC

Study

      

GWCL0403

33

133

47

122

80

255

GWMS0001

33

37

32

30

65

67

GWMS0106

51

69

27

37

78

106

Back to article page

Trials

ISSN: 1745-6215